Obsidio™ Conformable Embolic Registry
NCT: NCT06170619 · COMPLETED
NCT IDNCT06170619
StatusCOMPLETED
Start Date2024-06-19
Completion2025-09-09
Brief Summary
OCCLUDE is a prospective, post-approval, open-label, single arm, multi-center US registry of patients who undergo embolization with Obsidio™ Conformable Embolic. The purpose of this Registry is to assess effectiveness and safety outcomes of subjects who undergo embolization with Obsidio.
Frequently Asked Questions
What is Obsidio™ Conformable Embolic Registry?
Obsidio™ Conformable Embolic Registry is a clinical trial registered under NCT06170619. Current status: COMPLETED.
What is the status of NCT06170619?
The current status of NCT06170619 (Obsidio™ Conformable Embolic Registry) is: COMPLETED.
When did Obsidio™ Conformable Embolic Registry start?
Obsidio™ Conformable Embolic Registry started on 2024-06-19.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.